INTRODUCTION
============

The three-dimensional organization of eukaryotic cells depends on the transport of specific cargoes to their appropriate destinations within the cytoplasm. Long-range transport within cells, as exemplified by axonal transport, is mediated by microtubule-based motors, whereas local transport at the cell cortex is often mediated by actin-based motors. In several cases, different motors associate either directly or indirectly with the same cargo. Thus dynein motors bound to cargo are transported by kinesin toward the microtubule plus end during axonal anterograde transport, and kinesin rides back on dynein-powered cargo during retrograde transport toward the microtubule minus end. A similar microtubule-based transport setup exists for intraflagellar transport ([@B42]). Cargo transport along cytoskeletal elements is often mediated by more than one class of motor ([@B32]; [@B31]; [@B17]; [@B41]; [@B15]), and the different motors can influence each other's activities ([@B16]). For example, kinesin-2 and dynein both bind dynactin ([@B7]) and modulate each other's activities during intraflagellar transport ([@B35]), and a direct interaction between kinesin and myosin-Va has been reported ([@B19]). Indeed, there is a growing appreciation that cargoes often have two or more classes of motors associated with them ([@B1]) and, moreover, can influence each other's activities ([@B14]).

In budding yeast, polarized growth is dependent on the essential myosin-V, encoded by *MYO2*, which binds to its receptor, the Rab protein Sec4, on secretory vesicles to transport them along actin cables to sites of growth ([@B33]; [@B37], [@B36]; [@B23]; [@B34]). This myosin-V is also involved in segregation of organelles, each of which has an appropriate receptor. The first and best-studied example of a Myo2 receptor is Vac17, which binds the vacuolar protein Vac8, and both proteins are needed for vacuole segregation ([@B20]; [@B39], [@B40]; [@B11]; [@B43]). Similarly, Myo2 binds Mmr1 or Ypt11 for segregation of mitochondria ([@B22], [@B21]; [@B5]), Inp2 for segregation of peroxisomes ([@B12]), and Kar9 for orientation of the mitotic spindle ([@B44]).

A genetic screen identified a kinesin-related protein, named Smy1, whose overexpression suppresses the conditional mutation, *myo2-66*, that lies in the myosin-V motor domain ([@B25], [@B26]). Smy1 shows a similar polarized localization to Myo2 in growing yeast, and although it is not an essential protein, *smy1∆* is synthetically lethal with *myo2-66* ([@B26], [@B27]). Smy1 consists of a kinesin-like motor domain, a potential coiled-coil dimerization domain, and a C-terminal region that shows a two-hybrid interaction with the tail of Myo2 ([@B2]). These findings strongly suggest that it functions with Myo2, and since its localization is unaffected by perturbations of microtubules, its function was assumed to be microtubule independent. Moreover, *smy1∆* is synthetically lethal with the conditional mutation *sec4-8* and the conditional mutation *sec2-41*, affecting the guanine nucleotide exchange factor for Sec4 ([@B27]). These early studies concluded that Smy1 plays a microtubule-independent role that contributes in some way to polarization of secretory vesicles for growth ([@B27]). This idea was strengthened when it became clear that Myo2 is responsible for transport of secretory vesicles ([@B33]), and several new conditional mutations in *myo2* could also be suppressed by *SMY1* overexpression ([@B37]). Smy1 was later implicated as a Myo2-independent electrostatic tether of secretory vesicles to F-actin, allowing for processive transport of the vesicles by Myo2 along actin filaments ([@B18]). In addition, Smy1 has been suggested to bind Myo2 and be transported to the bud neck, where it dampens the F-actin--nucleating activity of the formin Bnr1 localized there ([@B6]; [@B10]). As noted by these authors, this function of Smy1 is unrelated to its ability to suppress the defect *myo2-66.* These studies suggest that Smy1 has several molecular functions.

Here we clarify the role that Smy1 plays with Myo2 in the secretory pathway. We exploit a genetic approach similar to the one we used to uncover the function of the nonessential Myo2-binding protein Mmr1 ([@B5]). For this, we first generated mutations in *MYO2* that have no overt phenotype except to render *SMY1* essential. Next, using these *myo2* alleles, we generated mutations in *SMY1* that confer temperature-sensitive growth. Analysis of the phenotype of these mutants reveals that Smy1 functions with Myo2 specifically in the delivery of secretory vesicles and not in transport of other cargoes. Moreover, Smy1 is shown to cooperate with Rab protein Sec4 and not with Ypt11, another Rab protein that binds Myo2 for mitochondrial inheritance, to specifically enhance an association of Sec4 and Myo2 for secretory vesicle transport. We also demonstrate that this function requires contributions from both the head and tail domains of Smy1, revealing the intricate nature of Smy1's function.

RESULTS
=======

Smy1 polarity depends on its association with Myo2
--------------------------------------------------

To explore whether Smy1 polarization is dependent on interaction with Myo2 ([@B2]) or secretory vesicles ([@B18]), we examined its localization in specific *myo2* mutants. We described temperature-sensitive mutations in the tail domain of Myo2 that confer defects in transport of secretory vesicles or inheritance of mitochondria ([@B37]; [@B5]). The conditional mutant *myo2-14* has a 35--amino acid truncation of the Myo2 tail that abolishes its two-hybrid interaction with Smy1 ([Figure 1A](#F1){ref-type="fig"}) and confers a conditional defect in mitochondrial inheritance ([@B5]). Consistent with the two-hybrid data, *SMY1* overexpression has no suppressive effect on the conditional growth of *myo2-14* but does suppress the conditional-growth phenotype of *myo2-12* and other tail domain mutations that confer a conditional defect in transport of secretory vesicles ([@B37]). In *myo2-14* cells, both Myo2 and the secretory vesicle marker Sec4 are polarized, yet Smy1 is not ([Figure 1, B and C](#F1){ref-type="fig"}). Thus, to be polarized, Smy1 requires an interaction with Myo2 and is not associated with secretory vesicles independently of Myo2 as suggested ([@B18]). To delineate the function of Smy1, we set out to generate mutations in *SMY1* that confer a conditional-growth phenotype. Analysis of such conditional mutants should reveal a function for Smy1.

![Smy1 polarity depends on its association with Myo2. (A) Yeast two-hybrid interactions between Myo2-cctail (aa 926--1575) fused to the activation domain (AD) and Smy1-MBD (aa 562--656) fused to the binding domain (BD). (B) Localization of Myo2, Smy1, and Sec4 in the indicated strains at 26°C and after being shifted to the restrictive temperature at 35°C for 1 h; each gene was tagged with three copies of the indicated fluorescent protein. Scale bars, 2 μm. (C) Quantification of small-budded cells (≤2 μm) with polarized Myo2, Sec4, and Smy1 at 26°C and after being shifted to 35°C for 1 h. Error bars, SD. *n* = 50.](2450fig1){#F1}

Isolation of conditional *myo2^sens^ smy1^ts^* mutants
------------------------------------------------------

Earlier work showed that cells lacking Smy1 grow well, and Myo2 remains polarized ([@B25]). The only reported phenotype of *smy1Δ* cells is the presence of thicker and more kinked actin cables ([@B6]; [@B10]). We confirm that *smy1Δ* cells grow well, and Myo2 is still polarized ([Figure 2, A and B](#F2){ref-type="fig"}). Phalloidin staining of actin showed little change in actin structures in *smy1∆* cells ([Figure 1B](#F1){ref-type="fig"}). Because the effects of *smy1∆* on actin cables are unrelated to the genetic relationships between Myo2 and Smy1 ([@B10]), we have not explored the reason for this apparent discrepancy, although it is worth noting that [@B10]) used the W303 genetic background, whereas our studies use the S288C background.

![Generation of *myo2^sens^ smy1^ts^* mutants. (A) Growth assay for WT and *smy1Δ* at 26 and 35°C. Growth of 10-fold serial dilutions on yeast extract/peptone/dextrose (YPD) plates after 2 d. (B) Myo2-3GFP and actin structures stained with phalloidin in the indicated mutants. Scale bars, 2 μm. (C, D) Schematic illustration of two-step mutagenesis for generating the *myo2^sens^ smy1^ts^* conditional mutants. (E) Synthetic lethality of *smy1Δ* with *myo2^sens^* alleles. All strains carry *CEN URA3 SMY1*. Growth of 10-fold diluted cells on SD --Ura, 5-FOA plates incubated at 26 and 35°C for 2 d. (F) Location of the mutations in the *smy1^ts^* alleles. (G) Growth of temperature-sensitive strains *myo2-41 smy1-15* and *myo2-57 smy1-12*. Tenfold serially diluted cells spotted on YPD plates at 26 and 35°C and incubated for 2 d. (H) Temperature sensitivity of *smy1^ts^* alleles is not due to Myo2 degradation and Sec4. Cells were grown at 26°C and harvested either directly or after being shifted to 35°C for 1 h. A 20-μg amount of total protein lysate was loaded into each lane. Myo2, Sec4, and G6PDH were detected by immunoblotting. See Supplemental Tables S1 and S2.](2450fig2){#F2}

Both the original *myo2-66* conditional head domain mutation, as well as many of our conditional *myo2* tail mutations, can be suppressed by *SMY1* overexpression, indicating a close functional relationship between Myo2 and Smy1 ([@B37]). Moreover, *myo2-66* shows synthetic lethality with *smy1Δ* ([@B25]). We generated chromosomal mutations in the tail region of Myo2 that alone confer no growth phenotype but render *SMY1* essential ([Figure 2, C and E](#F2){ref-type="fig"}). We recovered 17 such sensitized alleles (*myo2^sens^*), which have between one and four missense mutations (Supplemental Table S1). We selected four of these (*myo2-41*, *myo2-47*, and *myo2-51*, each with a single missense mutation, and *myo2-57*, with three) to generate 21 independent conditional mutations in chromosomal *SMY1* ([Figure 2D](#F2){ref-type="fig"} and Supplemental Figure S1A). Sequence analysis showed that these *smy1* temperature-sensitive alleles contain between one and four mutations (Supplemental Table S2). It is striking that almost all of the mutations lie in the head domain of Smy1 ([Figure 2F](#F2){ref-type="fig"}).

We selected the *myo2-41 smy1-15* conditional mutant for detailed study ([Figure 2G](#F2){ref-type="fig"}). The *myo2-41* mutation alone or in combination with *smy1-15* had no effect on the protein level of either Myo2 or its receptor Sec4 when shifted to 35°C for 1 h ([Figure 2H](#F2){ref-type="fig"}) or on the actin cytoskeleton when cells were grown at 26°C or shifted to 35°C (Supplemental Figure S1B). All of the strains grew normally at 26°C, and their division times were 90 ± 20 min at 26°C (20 cells for each strain). At the restrictive temperature of 35°C, the single *myo2-41* and *smy1-15* mutants grew normally, with division times of 80 ± 25 min (25 cells for each strain; mean ± SD).

The *myo2-41 smy1-15* mutant confers a conditional defect in binding secretory vesicles
---------------------------------------------------------------------------------------

The sensitizing mutation in *myo2-41* (I1462T) lies on the surface of the Myo2 tail adjacent to the Rab-binding site to which Sec4, Ypt31/32, and Ypt11 bind ([Figure 3A](#F3){ref-type="fig"}; [@B11]). The mutation in *smy1-15* (Y113H) lies in the kinesin-like motor domain ([Figure 3B](#F3){ref-type="fig"}). To explore the localization of Myo2 and Smy1 in these cells, we tagged each with different fluorescent proteins, which did not affect the growth characteristics of the strains. The Myo2 motors are polarized to the site of growth in *MYO2*, *myo2-41*, and *smy1-15* cells at both 26°C and after being shifted to 35°C ([Figure 3, C and E](#F3){ref-type="fig"}). When the double mutant *myo2-41 smy1-15* was shifted to the restrictive temperature for 1 h, the polarization of *myo2-41--*3 green fluorescent protein (3GFP) persisted, whereas *smy1-15*-3mCherry became depolarized. This depolarization of Smy1-3mCherry was also seen after a short shift to the restrictive temperature ([Figure 3C](#F3){ref-type="fig"}). We next sought to determine the effect of the mutations on secretory vesicle delivery. Secretory vesicles marked with chromosomally tagged GFP-Sec4 were polarized in the single mutants, but in the double *myo2-41 smy1-15* mutant, they were depolarized after a short shift to 35°C ([Figure 3, D and E](#F3){ref-type="fig"}). Thus the conditional *smy1-15* mutation results in both a dissociation of Smy1 from Myo2 and a defect in secretory vesicle transport at the restrictive temperature.

![The *myo2-41 smy1-15* mutant confers a conditional defect in binding secretory vesicles. (A) Location of the mutation in *myo2-41* (yellow) on the structure of the Myo2 tail. Subdomain I is in gray (aa 1152--1309) and subdomain II and linker in blue (aa 1310--1574). The mapped Rab-binding site ([@B11]) is shown in red. (B) Mutation in *smy1-15* allele (Y113H) is mapped to kinesin-like domain (KLD). (C, D) Localization of Myo2, Smy1, and Sec4 in the indicated strains at 26°C or after being shifted to 35°C for 1 h or 10 min for *myo2-41 smy1-15*. Scale bars, 2 μm. (E) Quantification of small-budded (≤2 μm) cells with polarized Myo2, Sec4, and Smy1 at 26°C and after being shifted to 35°C for 1 h. Mean values are from three independent experiments (*n* = 50 each), and error bars indicate SD. (F) Growth assay of *myo2-41* coupled with several *smy1^ts^* alleles. Tenfold serially diluted cells spotted on YPD plates at 26 and 35°C and incubated for 2 d.](2450fig3){#F3}

To determine whether the different *myo2^sens^* alleles might have yielded *smy1* alleles potentially affecting different functions, we combined *myo2-41* with 15 of the *smy1* alleles we had generated in different *myo2^sens^* backgrounds. All 15 grew at the permissive temperature and became inviable at the restrictive temperature ([Figure 3F](#F3){ref-type="fig"}), suggesting that all of the *smy1* alleles are affecting the same function. To document this further, we also characterized the single and double mutants of *myo2-57 smy1-12* and found that the same uncoupling of both secretory vesicles and Smy1 from polarized Myo2 occurred at the restrictive temperature (Supplemental Figure S2). Thus the combined genetic and localization data reveal that a critical function of Smy1 in the *myo2^sens^* strains is to link Myo2 to secretory vesicles.

The *myo2-41* allele compromises the ability of Myo2 to bind Sec4
-----------------------------------------------------------------

The sensitizing mutation in *myo2-41* lies adjacent to the Rab-binding site ([Figure 3A](#F3){ref-type="fig"}). Yeast two-hybrid analysis showed that *myo2-41* is compromised in its ability to interact with Sec4 ([Figure 4A](#F4){ref-type="fig"}), implying that Smy1 likely functions to enhance the interaction between Myo2 and Sec4 that is necessary for secretory vesicle transport. Consistent with this model, overexpression of *SEC4* from a multicopy plasmid suppresses the *myo2-41 smy1-15* mutant and results in repolarization of GFP-Sec4 ([Figure 4, B--D](#F4){ref-type="fig"}). Indeed, overexpression of *SEC4* suppresses all of the *myo2-41 smy1^ts^* mutants ([Figure 4E](#F4){ref-type="fig"}). However, overexpression of *SEC4* was unable to suppress the lethality of *myo2-41 smy1∆* ([Figure 4F](#F4){ref-type="fig"}). Therefore, even when *SEC4* is overexpressed, Smy1-15 still provides an essential function in *myo2-41 smy1-15* cells at the permissive temperature.

![The *myo2-41* allele compromises the ability of Myo2 to bind Sec4. (A) Yeast two-hybrid interactions between the WT or *myo2-41*-cctail (aa 926--1575) fused to the activation domain (AD) and Sec4ΔCC fused to the binding domain (BD). The C-terminal CXC motif of Sec4 was deleted to eliminate prenylation. (B) Overexpression of *SEC4* on a multicopy 2μ plasmid can suppress the *myo2-41 smy1-15* mutant. (C) Overexpression of *SEC4* restores the polarity of secretory vesicles in *myo2-41 smy1-15* at 35°C. Scale bar, 2 μm. (D) Quantitation of the percentage of small-budded cells with polarized GFP-Sec4 at 35°C in WT and *myo2-41 smy1-15*. Mean values are from three independent experiments (*n* = 50 each), and error bars indicate SD. (E) Overexpression suppression of *SEC4* on *myo2-41 smy1^ts^* mutants. Tenfold serially diluted cells spotted on YPD plates at 26 and 35°C and incubated for 2 d. (F) Growth of *myo2-41 smy1∆* or *myo2-57 smy1∆* with a *CEN URA3 SMY1* plasmid and *SEC4* on a multicopy 2μ plasmid. Cells were spotted on SD --Ura and 5-FOA plates with 10-fold serial dilutions.](2450fig4){#F4}

Smy1 enhances the association between Sec4 and Myo2 and their association with secretory vesicles
-------------------------------------------------------------------------------------------------

The interaction between Sec4 and Myo2 is difficult to capture by coimmunoprecipitation, presumably because it is relatively transient and only exists during transport and tethering of secretory vesicles. Thus, in immunoprecipitates of Myo2-3GFP, only a trace of endogenous Sec4 can be detected ([Figure 5A](#F5){ref-type="fig"}). Because Smy1 and Sec4 bind Myo2 ([@B2]; [@B34]), *SMY1* overexpression might enhance the Myo2/Sec4 interaction. Consistent with this model, when *SMY1* is overexpressed in an otherwise wild-type cell, a significant amount of endogenous Sec4 is recovered in Myo2-3GFP immunoprecipitates ([Figure 5A](#F5){ref-type="fig"}) without affecting the level of endogenous Myo2 or Sec4 ([Figure 5, B and C](#F5){ref-type="fig"}). Moreover, Smy1 is also recovered with Myo2 and Sec4.

![The association between Myo2 and Sec4 and with secretory vesicles is enhanced by full-length Smy1. (A) Coimmunoprecipitation of Myo2-3GFP in different Smy1 backgrounds (*smy1Δ, SMY1-3HA, SMY1-3HA* overexpression). Myo2-3GFP was immunoprecipitated, resolved by gel electrophoresis, and immunoblotted for GFP (Myo2), Sec4, and HA (Smy1). (B, C) Expression level of Myo2 and Sec4 in different Smy1 backgrounds. (B) A 20-μg amount of total protein lysate was loaded into each lane and immunoblotted for Myo2, Sec4, HA (Smy1), and tubulin. (C) Mean values from three independent Western blots; error bars indicate SD. (D, E) Number of Myo2-4IQ-3GFP motors per moving secretory vesicle. Data from puncta captured in three consecutive time-lapse frames. *n* = 50. Dotted white circle shows the mother cell. \*\*\**p* \< 0.0001. (F, G) Number of GFP-Sec4 per moving secretory vesicle. Data from puncta captured in three consecutive time-lapse frames. *n* = 50. \*\*\**p* \< 0.0001. (H) Coimmunoprecipitation of full-length Smy1 tagged with 3HA from different Smy1 constructs with or without coiled-coil domain tagged with 3GFP. (I) Smy1-3GFP puncta (arrows) on moving vesicle in WT. (J) Quantification of Smy1 homodimers per moving secretory vesicle. Data from puncta captured in three consecutive time-lapse frames. *n* = 50.](2450fig5){#F5}

To explore whether Smy1 expression affects the number of Myo2 motors or Sec4 receptors associated with secretory vesicles, we quantitated each in *SMY1*-, *smy1∆*-, and *SMY1*-overexpressing cells. To quantify the Myo2 molecules, we used as standard the 80 Cse4-3GFP centromeric histone molecules per anaphase cluster ([@B30]; [@B24]). Because the speed of transport of actively transporting secretory vesicles is very fast in wild-type cells and precludes estimating the number of these molecules on vesicles, we previously quantitated the number of molecules on the slower-moving secretory vesicles in cells in which the Myo2 protein had been altered to have 4IQ motifs rather than the normal 6IQ motifs, which has no effect on growth rate ([@B36]). In these Myo2-4IQ cells, secretory vesicles being actively transported use ∼40% of the total Myo2 in the cell, with each vesicle having ∼10 Myo2 motors ([@B8]). Using the same strategy, we confirm that there are ∼11 ± 4 (*n* = 52) Myo2 motors on moving secretory vesicles in Myo2-4IQ cells, and this is not significantly altered in *smy1∆* cells, 11 ± 5 (*n* = 45; [Figure 5, D and E](#F5){ref-type="fig"}). However, in cells overexpressing *SMY1*, in which the Smy1 level is enhanced ∼20-fold due its presence on a 2μ plasmid, the number of motors per transporting secretory vesicle is increased ∼1.5-fold, to 15 ± 4 (*n* = 60), representing ∼60% of all the motors in the cell ([Figure 5E](#F5){ref-type="fig"}). Also consistent with earlier results, there are 50 ± 14 (*n* = 50) and 47 ± 13 (*n* = 50) Sec4 molecules per secretory vesicle in wild-type and *smy1Δ* cells, respectively. Overexpression of *SMY1* also enhances the number of GFP-Sec4 receptors per transporting secretory vesicle by ∼1.5-fold to 75 ± 15 (*n* = 50; [Figure 5, F and G](#F5){ref-type="fig"}). Thus *SMY1* over­expression significantly enhances the number of Myo2 and Sec4 copies per secretory vesicle.

We also estimated the number of Smy1 molecules per secretory vesicle. Because Smy1 has a potential coiled-coil (CC) region between its head and tail, we first explored whether it has the ability to dimerize in vivo. Plasmids driving the expression of either Smy1-3GFP (Smy1-FL) or just the head (Smy1-KLD-3GFP, amino acids \[aa\] 1--382) or the head and coiled-coil region of Smy1 (Smy1-KLD + CC-3GFP, aa 1--562) were introduced into a strain expressing Smy1-3HA from its endogenous promoter. Smy1-3HA was immunoprecipitated, and both Smy1-3GFP and Smy1-KLD + CC-3GFP, but not Smy1-KLD-3GFP, were found to coimmunoprecipitate with it ([Figure 5H](#F5){ref-type="fig"}). Thus Smy1 can oligomerize through its CC domain, most likely existing as a homodimer in vivo. Quantitating the fluorescence in cells expressing Smy1-3GFP revealed that ∼22 Smy1 homodimers (22 ± 6; *n* = 46) are estimated to be present on each transporting secretory vesicle ([Figure 5, I and J](#F5){ref-type="fig"}). Given the possibility of a systematic difference in the fluorescence of GFP tagged to different proteins, the best we can conclude is that Smy1 and Myo2 are both in the range of 10--20 molecules per secretory vesicle, but the possibility of an excess of Smy1 over Myo2 remains open.

We also sought to estimate the number of Sec4 and Myo2 molecules in our conditional *myo2-41 smy1-15* mutant. We therefore tagged endogenous *SEC4* with GFP, and the amount of GFP-Sec4 per moving secretory vesicle in the single and double mutants both at 25°C and after a 5-min shift to the restrictive temperature. None of the single or double mutants at either temperature had a significantly different number of copies of GFP-Sec4 ([Figure 6A](#F6){ref-type="fig"}). As explained earlier, to count the Myo2 motors, we needed to reduce the number of IQ repeats in the *myo2-41* allele from the wild-type 6IQ to 4IQ to generate *myo2-4IQ-41*. Surprisingly, when we did this, the temperature sensitivity of *myo2-14 smy1-15* was eliminated, whether or not the *myo2-4IQ-41* was tagged ([Figure 6B](#F6){ref-type="fig"}). This allowed us to estimate the number of Myo2 dimers in the single and double mutants at the two temperatures. Consistent with robust growth, the number of Myo2 dimers was not significantly changed in these mutants ([Figure 6C](#F6){ref-type="fig"}). These unexpected results may provide additional insights into the function of Smy1, which we offer in the *Discussion*.

![Number of Sec4 and Myo2-4IQ-3GFP motors per secretory vesicle in *myo2 smy1* mutant. (A) Number of GFP-Sec4 per secretory vesicles in different strains at 26°C and after being shifted to 35°C for 5 min. Error bars, SD. (B) Growth assay of the indicated strains in which Myo2 has 6IQ or 4IQ motif. (C) Number of Myo2-4IQ-3GFP motors per secretory vesicle in different strains at 26°C and after being shifted to 35°C for 15 min. Error bars, SD.](2450fig6){#F6}

The tail domain of Smy1 is critical for its polarization, and the coiled-coil and head domains are essential for its function
-----------------------------------------------------------------------------------------------------------------------------

To dissect the contribution of the different domains in Smy1, we expressed several Smy1 constructs tagged with GFP behind the endogenous promoter in *smy1Δ* cells ([Figure 7A](#F7){ref-type="fig"}). Of these, only the full-length construct and one containing the CC and myosin-binding domain (MBD; Smy1-CC-MBD-3GFP) were polarized in otherwise wild-type strains ([Figure 7B](#F7){ref-type="fig"}). Further, whereas *SMY1* overexpression can suppress the temperature sensitivity of *myo2-12*, -*13*, -*16*, and -*66* ([@B37]), constructs overexpressing either a *SMY1* construct lacking the MBD (KLD + CC) or lacking the head domain (CC-MBD) cannot ([Figure 7C](#F7){ref-type="fig"}). Therefore the Smy1 coiled-coil and MBD are necessary for localization, and the full-length protein is required for its function. Consistent with this, overexpression of full-length *SMY1* enhanced the association of Sec4 with immunoprecipitated Myo2-3GFP, whereas overexpression of Smy1 lacking the head domain does not and was not recovered in the immunoprecipitates ([Figure 7D](#F7){ref-type="fig"}). Thus the head domain of Smy1 is critical for its function in enhancing the association between Myo2 and Sec4. In support of this conclusion, overexpression of either full-length *smy1-12* or *smy-15*, which carry missense point mutations in the head domain, were unable to suppress any of these conditional *myo2* alleles ([Figure 7C](#F7){ref-type="fig"}).

![The tail domain of Smy1 is critical for its polarization, and the head domain of Smy1 is essential for its functions. (A) Smy1 constructs generated, all with C-terminal 3GFP tags. CC, coiled-coil domain; KLD, kinesin-like head domain; MBD, myosin-binding domain. (B) Localization of the constructs in *smy1∆* cells. Scale bars, 2 μm. (C) Ability of full-length Smy1 (FL), KLD-CC domains, or the CC-MBD domains to suppress the indicated *myo2* conditional mutants. The constructs were overexpressed from a 2μ plasmid. Overexpression of wild-type *SMY1*, but not *smy1-12* or *smy1-15* can suppress the *myo2* conditional mutations. (D) GFP immunoprecipitates from Myo2-GFP cells overexpressing Smy1 or Smy1-CC-MBD blotted for GFP (Myo2), Sec4, Smy1, and tubulin.](2450fig7){#F7}

Smy1 function with Myo2 is restricted to the transport of secretory vesicles
----------------------------------------------------------------------------

Myo2 is involved in the segregation of essentially all organelles during the cell cycle ([@B3]). One of these, mitochondria, also involves an interaction with a Rab protein, Ypt11 ([@B22]). Active segregation of mitochondria requires an association of Myo2 with either Mmr1 or Ypt11, and in the absence of this segregation, yeast is inviable ([@B21]; [@B5]). Mutations that reduce Ypt11 binding to the Rab-binding site of the Myo2 tail render *MMR1* essential ([@B5]). Because *myo2-41* also has a defect in Rab binding, we examined whether *myo2-41 smy1-15* might have a defect in mitochondrial distribution, which would suggest that Smy1 is also implicated in mitochondrial inheritance. Whereas GFP-Sec4 polarization is strongly affected in *myo2-41 smy1-15* cells at 35°C, there is no significant defect in mitochondrial inheritance, suggesting that Smy1 function may be specific to coupling secretory vesicles with Myo2 motors ([Figure 8, A and B](#F8){ref-type="fig"}). Further, the *myo2-41* and *myo2-57* mutations, which render *SMY1* essential, have no growth defect at any temperature when combined with *mmr1∆*, which makes mitochondrial inheritance dependent on the Myo2-Ypt11 interaction ([Figure 8C](#F8){ref-type="fig"}).

![Smy1 function with Myo2 is restricted to the transport of secretory vesicles. (A) Wild-type and *myo2-41 smy1-15* cells expressing GFP-Sec4 and the mitochondrial marker Mito-RFP after being shifted to 35°C for 1 h. Scale bars, 2 μm. (B) Percentage of cells with mitochondria in the buds at 26°C or after being shifted to 35° for 1 h. Mean values from three independent experiments (*n* = 50); error bars, SD. (C) Effect of *mmr1Δ* on the growth of *myo2-41* and *myo2-57* for 2 d at 26 and 35°C. (D) Growth of cells overexpressing *SEC4* or *SMY1* in WT and *mmr1∆* cells. (E, F) Overexpression of *SEC4* or *SMY1* in WT and *mmr1Δ* cells expressing GFP-Sec4 and Mito-RFP. Scale bars, 2 μm. (G) Percentage of small-budded cells (≤2 μm) with polarized vesicles (GFP-Sec4) and mitochondria (Mito-RFP) in the bud upon overexpression of *SEC4* or *SMY1*. Mean values from three independent experiments (*n* = 100 each); error bars, SD. (H) Mitochondrial inheritance in cells overexpressing Smy1-CC + MBD in WT and *mmr1Δ* cells. Scale bars, 2 μm.](2450fig8){#F8}

To explore in a different manner whether Smy1 can enhance the association of Rab proteins other than Sec4 with Myo2, we looked in more detail at mitochondrial inheritance. In *mmr1∆* cells, mitochondrial inheritance is dependent on Ypt11, whose binding site overlaps with Sec4 on domain II of Myo2 ([@B11]). If Smy1 enhances the binding of all Rab proteins to the Myo2 tail, its overexpression might enhance mitochondrial inheritance. However, if it is specific for Sec4, *SMY1* overexpression might compromise the availability of the Myo2 tail to bind Ypt11. To test this idea, we initially examined whether Sec4 overexpression compromised mitochondrial inheritance in *MMR1* and *mmr1∆* cells. Although the cells remain viable ([Figure 8D](#F8){ref-type="fig"}), there is a clear defect in mitochondrial inheritance in *mmr1∆* cells, with most of the mitochondria being retained in the mother cell ([Figure 8, E--G](#F8){ref-type="fig"}). Similarly, when *SMY1* is overexpressed in *mmr1∆* cells, there is a defect in mitochondrial inheritance ([Figure 8, E--G](#F8){ref-type="fig"}), showing that Smy1 functions with Sec4 and not with Ypt11. This effect is only seen when full-length *SMY1* is overexpressed, as no defect is seen when Smy1-CC-MBD is overexpressed, further indicating that the Smy1 head domain is necessary for its function ([Figure 8H](#F8){ref-type="fig"}). Thus our data imply that Smy1's role is specific to secretory vesicles.

DISCUSSION
==========

The mechanism by which molecular motors are activated and bind and transport specific cargoes is critical for understanding the functional organization of cells. The myosin-V class of motors is found in all fungi and animal cells, as well as in plants, where they are called myosin-X1 motors ([@B15]). Myosin-Vs are well known to bind Rab proteins: mammalian myosin-Vs have been shown to bind Rabs 8, 10, and 11 directly and Rab27a indirectly through melanophilin ([@B15]). In yeast, Myo2 binds four of the 11 Rab proteins: Ypt31/32 ([@B28]), Sec4 ([@B23]; [@B34]), and Ypt11 ([@B22]; [@B11]; [@B5]).

Since its identification \>20 yr ago as an overexpression suppressor of the conditional *myo2-66* mutation, the specific function of Smy1 has been mysterious. The early genetic data discussed in the *Introduction* made a strong case that it functions with Myo2 and is involved in some aspect of the late secretory pathway. Here we generated *myo2^sens^* mutations that confer no obvious phenotype except to render *SMY1* essential, allowing for subsequent isolation of conditional mutations in *SMY1*. Analysis of the phenotype of *myo2^sens^ smy1* conditional mutants reveals a clear defect in the transport of post-Golgi secretory vesicles, very similar to the phenotype of conditional *myo2* mutations that affect this function. This is a clear indication that Smy1's function is to cooperate with Myo2 in secretory vesicle transport. Additional support for this conclusion and for the specificity of this function is discussed later.

The reported two-hybrid interaction between the tail of Myo2 and the tail of Smy1 was not readily reproduced in vitro or by coimmunoprecipitation, so its validity was questioned ([@B2]; [@B18]). Here we show that the polarized colocalization of Smy1 with Myo2 is lost when either a *myo2* mutant defective in binding Smy1 is examined or when Smy1 lacking the MBD is expressed. Further, the region of Smy1 necessary for the two-hybrid interaction is also necessary for its ability to suppress conditional *myo2* mutations. In cells in which Smy1 is overexpressed, Smy1 is recovered in immunoprecipitates of endogenous Myo2. These results make a compelling case for the relevance of the original Myo2-Smy1 two-hybrid interaction ([@B27]).

We have also delineated functions for the other two domains of Smy1, the coiled-coil region and the kinesin-related motor domain. The coiled-coil region is required, with the Myo2-binding region, for the polarized distribution of Smy1. This is almost certainly because the coiled-coil region is necessary for the dimerization, or oligomerization, of the protein. One intriguing possibility is that the binding of just one Myo2-binding region to Myo2 is not of sufficient affinity to localize the protein, whereas the combination of two low-affinity sites may be sufficient. The head domain is not polarized on its own or in constructs together with the coiled-coil domain, thus revealing that the Myo2-binding region is necessary for Smy1's polarized distribution. Although just the construct lacking the head domain of Smy1 is polarized, the full-length protein (KLD-CC-MBD) is necessary to suppress the conditional *myo2* mutations and provide the essential function in our newly generated *myo2^sens^* alleles. Therefore the kinesin-like head is a functionally important domain of Smy1.

What is the precise function of Smy1? In otherwise wild-type cells, we found that *SMY1* overexpression enhances the association of Sec4 with Myo2, as assessed by coimmunoprecipitation, and also enhances the number of Sec4 receptors and Myo2 motors on secretory vesicles. One simple possibility that we favor and is consistent with our data is that Myo2/Sec4-GTP/Smy1 forms a ternary complex in which Smy1 enhances the association between Myo2 and Sec4. The finding that there are sufficient Smy1 molecules, and an excess of Sec4 receptors, to engage all the Myo2 motors on transporting secretory vesicles is consistent with this model. So far, our attempts to reconstitute a Myo2/Sec4/Smy1 complex on lipid vesicles has not been successful; the conditions might not be correct, such as a specific lipid or curvature requirement, or another protein might be required. If another factor functions with Smy1 in this process and this function is essential, deletion of the gene for the factor should be synthetically lethal with *smy1∆*. We therefore explored the literature and databases for genetic interactions that might support this possibility. As mentioned earlier, *smy1∆* is synthetically lethal with my*o2-66*, *sec4-8*, and *sec2-41* ([@B27]). The Saccharomyces Genome Database reports that *smy1∆* is synthetically lethal with *bem1∆*, *bem2∆*, *bni1∆*, and *cla4∆*, each of which affects the integrity of actin cables, the substrate on which Myo2 transports secretory vesicles. No obvious candidates functioning with Smy1 are found among the other reported genetic or biochemical interactions. Thus we believe that Smy1 functions to make the interaction between Myo2 and Sec4 more robust, perhaps using a coincidence detection mechanism to enhance specificity.

We were initially surprised to find that shortening of the *myo2-41* neck domain from 6IQ motifs to 4IQ fully suppressed the temperature-sensitive growth phenotype of the *myo2-41 smy1-15* mutant. However, this result further clarifies the role of the cooperation between Smy1 and Sec4 in binding Myo2. We showed that Myo2 is activated by binding to secretory cargo ([@B8]). We also showed that wild-type Myo2 undergoes a head-to-tail interaction that regulates the activity of Myo2. Moreover, the *MYO2-4IQ* allele, although not affecting the overall growth rate, partially activates the motors, resulting in a higher percentage of active motors ([@B9]). The finding that partial activation of Myo2 can overcome the temperature sensitivity suggests that the problem in the *myo2-14 smy1-15* strain is in motor activation of Myo2. The *myo2-41* mutation reduces the affinity for Sec4, which presumably impairs Sec4's ability to activate Myo2 and therefore makes Myo2 activation dependent on Smy1. This strongly suggests that Smy1 cooperates with Sec4 in the activation step of Myo2 for transport of secretory vesicles. Remarkably, in the Myo2-4IQ background, the number of motors on secretory vesicles is independent of the *myo2-41* or *smy1-15* mutation, possibly suggesting that the cell has a robust mechanism to regulate motor number on secretory vesicles.

What is the biological function of Smy1's kinesin-like head domain? Essentially all of the mutations we generated to make the conditional *smy1* alleles were found to lie in the head, underscoring the importance of this region for the function of Smy1. This is surprising, as one would expect the mutations to lie in the Myo2-binding region. However, it is possible that mutations in the Myo2-binding region are too severe to generate a conditional phenotype, whereas subtle perturbations in the Smy1 head may be more easily tolerated. In support of this, there are no obvious mutational hotspots in the head, suggesting that a variety of small perturbations may be able to generate a conditional phenotype. Whatever the reason, this emphasizes that the head is functionally important. One possible function it might have is to bind Sec4, but we have not been able to detect a two-hybrid interaction between Sec4 and Smy1's head domain. Another possibility is that Smy1's head binds to another component present on secretory vesicles, enhancing the association of Myo2 with them and possibly indirectly enhancing the number of Sec4 receptor molecules.

The cooperation between Sec4 and Smy1 in the Myo2-dependent transport of secretory vesicles is reminiscent of the involvement of the mitochondrial receptors Mmr1 and the Rab Ypt11 in the segregation of mitochondria, another essential function of Myo2 ([@B5]). This similarity is underscored by the finding that Sec4 and Ypt11 bind to the same Rab-binding site on the Myo2 tail ([@B11]) and that overexpression of Sec4 negatively affects mitochondrial inheritance in an *mmr1∆* strain. Moreover, in both cases, the receptors Mmr1 and Ypt11, and Sec4 and Smy1, bind directly to Myo2. A significant difference is that Mmr1 or Ypt11 can each provide the essential bridge to Myo2 for mitochondrial inheritance, whereas Smy1 cannot provide the essential secretory vesicle function, as loss of Sec4 cannot be bypassed by Smy1 overexpression. This may be because Sec4 has the additional essential function of binding the exocyst for vesicle tethering. There are no *sec4* separation-of-function alleles that affect just transport and not tethering and could be used to address whether Smy1 alone is sufficient for coupling Myo2 to secretory vesicles.

Our genetic data strongly imply that Smy1's role is specific to secretory vesicles. First, overexpression of Smy1, by which the association between Sec4 and Myo2 is enhanced, compromises the Ypt11-Myo2 interaction necessary for mitochondrial inheritance in *mmr1∆* cells. Moreover, our *myo2^sens^* mutations, which render *SMY1* essential and compromise the interaction of Sec4 with the Myo2 tail, have no effect on mitochondrial inheritance even in an *mmr1∆* background.

In summary, we found that an important function of Smy1 is to cooperate with Myo2 and Sec4 in the transport of secretory vesicles for polarized growth. It is not clear why a kinesin-related protein should perform this function. It is possible that it derives from an evolutionary relic reflecting a time when secretory vesicles were first transported by a kinesin on microtubules and then by a myosin-V on actin filaments, making their association and functional interplay meaningful. The report of a direct interaction between mammalian kinesin and myosin-Va ([@B19]) supports such a possibility.

MATERIALS AND METHODS
=====================

Yeast strains and transformation
--------------------------------

Yeast strains and plasmids used in this study are listed in Supplemental Tables S3 and S4, respectively. Standard media and techniques for yeast growing and transformation were used ([@B38]). Briefly, for transformation, 5 ml of log-phase OD~600~ ≈ 0.8 cells were harvested and resuspended in a mixture of 36 μl of 1 M lithium acetate, 240 μl of 50% polyethylene glycol 3350 (wt/vol), 50 μl of salmon-sperm DNA 10 mg/ml, 1 μg of DNA constructs, and volume-adjustable 29 μl of H~2~O ([@B13]). Cells were incubated at 42°C for 45 min, and transformants were selected on selective synthetic dropout (SD) medium plates. Gene deletion and chromosomal GFP tagging were performed by standard PCR-mediated techniques ([@B29]). Plasmids from yeast were isolated using the plasmid isolation kit (YeaStar Genomic DNA kit; Zymo Research, Irvine, CA).

Screen for *myo2*-sensitized alleles (*myo2^sens^*)
---------------------------------------------------

The *myo2* mutant library cloned into pRS303 ([@B5]) was used. Briefly, the Myo2 tail (aa 1119--1574) was PCR mutagenized with forward primer 5′MYO2, *Cla*I-GATAATGAAAT­CGATATTATGGAAGA, and reverse primer 3′MYO2, *Bam*HI-CGGGATCCATTATCATACTATACTATTGACAAATACTTC, to make five independent DNA libraries ([@B37]). When cut with *Spe*I and transformed into yeast, the library plasmid replaces the *Eco*RI--*Cla*I region of *MYO2* with the mutagenized sequence. DNA from each library was transformed into the *smy1Δ*+pRS316-*SMY1* strain with selection on SD --Ura --His plates at 26°C. Approximately 200 colonies/plate with 20 plates were replicated on SD --His + 5-fluoro-orotic acid (5-FOA) and incubated at 26°C for 3 d to detect which *myo2* mutant alleles could not grow in the absence of the pRS316-*SMY1* plasmid. Thirty-three candidates that did not grow on SD --His +5-FOA were chosen and reconfirmed. Seventeen *myo2^sens^* mutants were confirmed and sequenced to identify their mutations.

Error-prone PCR of *SMY1* and plasmid mutant library construction
-----------------------------------------------------------------

Error-prone PCR was performed as described ([@B4]). The final concentration of 0.15 mM MnCl~2~ was used during 10 PCR cycles, giving a mutagenesis rate of ∼0.67/1000 nucleotides (nt). To construct a *smy1* mutant library, we used forward primer 5′SMY1, *Not*I-TGAATGTTTGAATAGTAATG, located −300 nt upstream of the Smy1 translation start site (ATG), and reverse primer 3′SMY1, *Bam*HI-TTTCAATTTTTCTCATTTTTC, located 179 nt downstream of the Smy1 stop codon, to PCR amplify and mutagenize *SMY1*. An upstream fragment (−300 to −600 upstream of the start site) that creates the first crossover for homologous recombination was amplified using *Bam*HI-ACATCAAGATTATAGCTGTC and *Xho*I-CAATCACAGTGTATTATCTC primers. This fragment was cloned into pRS304 (*TRP1*) backbone vector after cutting with *Bam*HI and *Xho*I to generate pRS304-HR. The mutant *SMY1* library was cut with *Not*I and *Bam*HI and ligated into the pRS304-HR vector to generate a pRS304-HR-*SMY1* library. To collect a sufficient mutant library, 10,000 colonies were grown on Luria broth (LB) + ampicillin plates and amplified. Before transforming the mutant library into yeast cells, the pRS304-HR-*SMY1* plasmid was linearized with *Bam*HI.

Screen for conditional *smy1* mutants
-------------------------------------

Transformation of the strains carrying the *myo2-41*, *myo2-43*, *myo2-51*, and *myo2-57* alleles (ABY3319, ABY3318, ABY3317, and ABY3316) with the pRS304-HR-*SMY1* plasmid library with selection on SD --His --Trp was used to generate new *SMY1* alleles. Approximately 200 transformants/plate on 15 plates were grown at 26°C for 3 d. Plates were then replicated on another SD --His --Trp plate and incubated at 37°C for 3 d to detect which *smy1* mutant alleles cannot grow at 37°C. Twenty-one *smy1^ts^* alleles were recovered after retesting and then sequenced.

Plasmid construction
--------------------

The integrating plasmids pRS306 GFP-Sec4 (*URA3*) and pRS306 Myo2cctail-3GFP (*URA3*) used to tag Sec4 and Myo2 have been described ([@B8]). To create pRS305 Smy1cctail-3mCherry for chromosomal integration, the C-terminal half of *SMY1* (nt 1000--1968) was amplified and ligated into the pRS305 vector between *Xho*I and *Bam*HI. 3mCherry was cloned between *Bam*HI and *Not*I. For homologous recombination, the 3′ region of *SMY1* between the *Not*I and *Sac*I sites (427 nt) was ligated into the vector. The vector was linearized by *Hin*dIII before transformation. For 3 hemagultinin (3HA) tagging at the chromosomal *SMY1* gene, the 3mCherry from pRS305 Smy1cctail-3mCherry was replaced with 3HA. The functional construct was verified by Western blotting using anti-HA antibody (16B12 \[ab130275\]; Abcam, Cambridge, MA). For overexpression constructs, the *SMY1* open reading frame flanked by 1000 nt upstream and downstream was cloned into YEp351 between the *Xma*I and *Pst*I sites. The functional construct was verified by Western blotting with Smy1 antibody. For creating Myo2-4IQ in BY4741 background, the integrating plasmid pRS303 Myo2-4IQ was constructed as described ([@B36]). To create pRS303 myo2-4IQ-41, mutation of I1462T in the Myo2 cargo--binding region was introduced by PCR-based site-directed mutagenesis.

Smy1 antibody generation
------------------------

*SMY1* tagged with *SUMO* was expressed in Rosetta 2(DE3) pLysS competent. Bacterially expressed Smy1-SUMO was selected on Ni^2+^ resin, and then the SUMO tag was cleaved with Ulp1. The SUMO-cleaved Smy1p was gel purified, and antibodies were generated commercially (Pocono Rabbit Farm and Laboratory, Canadensis, PA).

Microscopy
----------

Micrographs were acquired on a CSU-X spinning-disk confocal microscopy system (Intelligent Imaging Innovations) with a DMI 6000B microscope (Leica), 100×/1.45 numerical aperture objective, and a QuantEM electron-multiplying charge-coupled device (CCD) camera (Photometrics) or an HQII CCD camera (Photometrics) with 2× magnifying lens. All images shown are maximum projection of seven confocal slices taken 0.28 μm apart, unless stated otherwise. Images were analyzed and processed with SlideBook 6.0 software (Intelligent Imaging Innovations). The images were further adjusted in Photoshop (Adobe) to give the clearest presentation of the results and assembled in Illustrator (Adobe). For live-cell imaging of yeast cells, cells were attached to a glass-bottomed dish coated with concanavalin A (EY laboratories) and washed with respective cell medium. Imaging at high temperatures was performed in an environmental chamber (Okolab). Quantification of the fluorescent proteins on transporting secretory vesicles was done as described ([@B8]). Staining cells with phalloidin has also been described ([@B8]).

Yeast two-hybrid constructs and analysis
----------------------------------------

The coding sequence for Myo2cctail (nt 2776--4725) was fused with the DNA activation domain in pGADT7 vector between *Nde*I and *Bam*HI. The Smy1 myosin-binding domain (nt 1308--1968) was fused with the DNA-binding domain in pGBKT7. The AH109 strain cotransformed with both plasmids was selected in medium lacking leucine and tryptophan (SD-2DO, double dropout). Interaction was detected by growth on medium lacking leucine, tryptophan, and histidine (SD-3DO, triple dropout).

Immunoblotting
--------------

Overnight cultures were harvested and resuspended in disruption buffer (20 mM Tris-Cl, pH 7.9, 10 mM MgCl~2~, 1 mM EDTA, 5% glycerol, 1 mM dithiothreitol, 0.3 M ammonium sulfate, 1 mM phenylmethylsulfonyl fluoride, and 1× Sigma yeast protease inhibitor cocktail \[Sigma-Aldrich, St. Louis, MO\]) with 0.1 g of acid-washed glass beads (Sigma-Aldrich). Vigorous vortexing was done at 4°C for three times with 1 min each and 1 min in between resting on ice. The crude lysates were centrifuged at 17,000 × *g* in a table-top centrifuge in a cold room (4°C) for 10 min, and supernatant was collected. For temperature-sensitive strains, cells were grown at 26°C overnight and adjusted to log-phase OD~600~ = 0.8 the next day. Cells were then shifted to 35°C for 2 h. On harvesting, cells were chilled on ice, washed twice with ice-cold water, frozen in dry ice, and stored at *−*80°C. The concentrations of protein samples were measured using the Bradford assay. The samples were resolved by SDS--PAGE, transferred to Immobilon-P membrane (Millipore), and then blocked for 1 h in 5% milk in phosphate-buffered saline/0.1% Tween. Membranes were incubated with primary antibodies for 1 h: mouse monoclonal anti-GFP antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or rabbit polyclonal antibody against Myo2tail, Smy1, and Sec4 (generated in the lab) and glucose-6-phosphate dehydrogenase (G6PDH). After being washed, membranes were incubated with secondary antibodies: IRDye goat anti-mouse and donkey anti-rabbit antibodies. Membranes were analyzed using the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE).

Coimmunoprecipitation
---------------------

Total yeast protein extracts were prepared using the same protocols described earlier. A 10-μl amount of GFP-Trap resin (ChromoTek) was used for 1 mg of each cell lysate and agitated at 4°C for 2 h. Bound protein was eluted with 50 μl of hot (95°C) SDS--PAGE loading buffer. Eluted proteins were resolved on 7--15% split SDS gels.
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